Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NEUROPSYKOLOGISK KLINIK HILLERØD ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.0% 9.4% 9.1% 5.1% 5.5% 5.7% 15.9% 15.9%   Credit score (0-100)   45 26 26 43 40 40 12 12   Credit rating   BBB BB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   344 171 -31.3 68.3 99.7 121 0.0 0.0   EBITDA   256 -54.8 -94.9 3.7 -24.8 -110 0.0 0.0   EBIT   256 -54.8 -94.9 3.7 -24.8 -110 0.0 0.0   Pre-tax profit (PTP)   248.2 -61.2 -19.2 49.6 43.9 -31.3 0.0 0.0   Net earnings   163.4 -24.4 -44.9 47.4 68.0 -26.7 0.0 0.0   Pre-tax profit without non-rec. items   248 -61.2 -19.2 49.6 43.9 -31.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   767 743 698 745 813 786 385 385   Interest-bearing liabilities   0.0 25.1 25.1 32.7 31.4 24.5 0.0 0.0   Balance sheet total (assets)   892 860 764 842 923 889 385 385   Net Debt   -728 -636 -440 -411 -438 -310 -385 -385     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   344 171 -31.3 68.3 99.7 121 0.0 0.0   Gross profit growth   -52.9% -50.1% 0.0% 0.0% 46.0% 21.6% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   892 860 764 842 923 889 385 385   Balance sheet change%   -4.2% -3.6% -11.2% 10.2% 9.6% -3.7% -56.6% 0.0%   Added value   256.2 -54.8 -94.9 3.7 -24.8 -110.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   74.5% -32.0% 303.3% 5.4% -24.8% -91.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   27.2% -7.0% -2.1% 6.3% 5.0% -3.5% 0.0% 0.0%   ROI %   33.3% -8.0% -2.3% 6.8% 5.5% -3.8% 0.0% 0.0%   ROE %   22.1% -3.2% -6.2% 6.6% 8.7% -3.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   86.0% 86.4% 91.3% 88.5% 88.1% 88.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -284.1% 1,158.9% 464.2% -11,169.2% 1,769.4% 280.6% 0.0% 0.0%   Gearing %   0.0% 3.4% 3.6% 4.4% 3.9% 3.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 1.0% 7.3% 4.5% 1.6% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   6.0 6.2 8.4 6.0 5.4 4.8 0.0 0.0   Current Ratio   6.0 6.2 8.4 6.0 5.4 4.8 0.0 0.0   Cash and cash equivalent   727.9 660.7 465.6 444.1 469.4 334.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   627.6 609.5 487.1 487.4 488.4 385.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   256 -55 -95 4 -25 -110 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   256 -55 -95 4 -25 -110 0 0   EBIT / employee   256 -55 -95 4 -25 -110 0 0   Net earnings / employee   163 -24 -45 47 68 -27 0 0